October 1, 2024
MADRID — Metformin is taken every day by more than 200 million people worldwide. Its value as a glucose-lowering agent has been established for decades. But […]
October 1, 2024
MADRID — Individuals with type 2 diabetes and/or obesity plus one or more metabolic risk factors are at a higher risk for metabolic dysfunction–associated steatotic liver […]
October 1, 2024
TOPLINE: National foot screening programmes for patients with diabetes began in 2004 in England and 2006 in Scotland. The number and quality of studies to support […]
October 1, 2024
TOPLINE: For patients with type 1 diabetes (T1D), a positive test or hospitalization for COVID-19 increases the risk of developing hypertension, chronic kidney disease (CKD), and […]
September 27, 2024
MADRID — Airplane travel consistently causes insulin pumps to over-deliver a little over half a unit on takeoff and under-deliver a bit less on landing, new […]
September 27, 2024
TOPLINE: A real-world comprehensive program dedicated to the care of young adults with type 1 diabetes (T1D) led to more meaningful improvements in hospitalization rates, automated […]
September 26, 2024
TOPLINE: Diabetes is associated with a lower incidence of uterine fibroids in midlife women receiving diabetes treatment, especially metformin. The association between diabetes and the risk […]
September 25, 2024
MADRID — High-quality data from European diabetes registries are essential for informed decision-making in clinical practice, research, policy, and regulation, experts said during a session at […]
September 25, 2024
TOPLINE: The prevalence of diabetes in the United States increased by 18.6% from 2012 to 2022, with notably higher rates among racial and ethnic minorities, men, […]